InMed Pharmaceuticals Inc. announced the appointment of Bruce S. Colwill, CPA, CA as Chief Financial Officer, effective August 9, 2019. Mr. Colwill join in the company with over twenty five years of experience in financial leadership roles. Prior to this company, Mr. Colwill served as Chief Financial Officer of General Fusion Inc, since October 2016.

Contemporaneous with Mr. Colwill's appointment, InMed will be consolidating the roles of Chief Financial Officer and Chief Business Officer into one position, that of Chief Financial Officer. Jeff Charpentier will be stepping down from the CFO role but will continue as part of the InMed team in a role with a reduced time commitment. In addition, CBO Josh Blacher has decided to leave InMed to pursue another opportunity in the investment management industry.

Management has taken efforts to ensure a smooth transition.